Sean Parker’s immunotherapy leader moves on
Jeffrey Bluestone, the UCSF scientist tapped to run billionaire Sean Parker’s immunotherapy institute back in 2016, has stepped down to run a company of his own.
As STAT’s Matthew Herper reports, Bluestone’s next act is leading Sonoma Biotherapeutics, a startup developing genetically altered immune cells to treat cancer. The company raised $40 million to get started, drawing from a syndicate that includes Arch Venture Partners and 8VC.
Bluestone’s departure means the Parker Institute for Cancer Immunotherapy, launched with a $250 million commitment from its namesake, will need new leadership.
Read more.
As STAT’s Matthew Herper reports, Bluestone’s next act is leading Sonoma Biotherapeutics, a startup developing genetically altered immune cells to treat cancer. The company raised $40 million to get started, drawing from a syndicate that includes Arch Venture Partners and 8VC.
Bluestone’s departure means the Parker Institute for Cancer Immunotherapy, launched with a $250 million commitment from its namesake, will need new leadership.
Read more.
.png)
No hay comentarios:
Publicar un comentario